Overcoming the shortfalls of ibrutinib with fludarabine in CLL patientss
PDL1 and CD38 antigen expression in NSCLC
What can be learnt about using interferon in patients with myelofibrosis?
The road to individualized treatment for CLL
Standardising CLL patient stratification globally